ZNF320
gene geneOn this page
Also known as ZFPLDKFZp686G16228
Summary
ZNF320 (zinc finger protein 320, HGNC:13842) is a protein-coding gene on chromosome 19q13.41, encoding Zinc finger protein 320 (A2RRD8). May be involved in transcriptional regulation.
ZNF320 encodes a Kruppel-like zinc finger protein. Members of this protein family are involved in activation or repression of transcription.
Source: NCBI Gene 162967 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 74 total
- MANE Select transcript:
NM_001351774
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13842 |
| Approved symbol | ZNF320 |
| Name | zinc finger protein 320 |
| Location | 19q13.41 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZFPL, DKFZp686G16228 |
| Ensembl gene | ENSG00000182986 |
| Ensembl biotype | protein_coding |
| OMIM | 606427 |
| Entrez | 162967 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 27 protein_coding, 6 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000391781, ENST00000593618, ENST00000594408, ENST00000594741, ENST00000595202, ENST00000595635, ENST00000596215, ENST00000597091, ENST00000597111, ENST00000597265, ENST00000597856, ENST00000598199, ENST00000600930, ENST00000601334, ENST00000673631, ENST00000682928, ENST00000855873, ENST00000855874, ENST00000855875, ENST00000855876, ENST00000855877, ENST00000855878, ENST00000855879, ENST00000919701, ENST00000919702, ENST00000919703, ENST00000919704, ENST00000919705, ENST00000919706, ENST00000919707, ENST00000919708, ENST00000919709, ENST00000919710, ENST00000952398
RefSeq mRNA: 14 — MANE Select: NM_001351774
NM_001351773, NM_001351774, NM_001351775, NM_001351776, NM_001351777, NM_001387570, NM_001387571, NM_001387572, NM_001387573, NM_001387574, NM_001387575, NM_001387576, NM_001387577, NM_207333
CCDS: CCDS33095, CCDS92678
Canonical transcript exons
ENST00000682928 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003167046 | 52897520 | 52897635 |
| ENSE00003173698 | 52891229 | 52891346 |
| ENSE00003173861 | 52893779 | 52893856 |
| ENSE00003226247 | 52876180 | 52881983 |
| ENSE00003796257 | 52890241 | 52890328 |
| ENSE00003896264 | 52888127 | 52888253 |
Expression profiles
Bgee: expression breadth ubiquitous, 239 present calls, max score 97.94.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.1599 / max 149.6492, expressed in 1584 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182537 | 10.1599 | 1584 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 97.94 | gold quality |
| oviduct epithelium | UBERON:0004804 | 96.30 | gold quality |
| pancreatic ductal cell | CL:0002079 | 92.93 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 89.76 | gold quality |
| endometrium | UBERON:0001295 | 89.28 | gold quality |
| right uterine tube | UBERON:0001302 | 88.95 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 88.64 | gold quality |
| metanephros cortex | UBERON:0010533 | 87.23 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 87.12 | gold quality |
| fallopian tube | UBERON:0003889 | 86.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.75 | gold quality |
| cortical plate | UBERON:0005343 | 86.60 | gold quality |
| endothelial cell | CL:0000115 | 86.56 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 85.95 | gold quality |
| colonic epithelium | UBERON:0000397 | 85.89 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 85.72 | gold quality |
| stromal cell of endometrium | CL:0002255 | 85.65 | gold quality |
| cerebellar cortex | UBERON:0002129 | 85.49 | gold quality |
| uterus | UBERON:0000995 | 85.20 | gold quality |
| ovary | UBERON:0000992 | 85.06 | gold quality |
| body of uterus | UBERON:0009853 | 84.99 | gold quality |
| right ovary | UBERON:0002118 | 84.80 | gold quality |
| body of pancreas | UBERON:0001150 | 84.75 | gold quality |
| left ovary | UBERON:0002119 | 84.63 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.57 | gold quality |
| urinary bladder | UBERON:0001255 | 84.51 | gold quality |
| cerebellum | UBERON:0002037 | 84.51 | gold quality |
| pancreas | UBERON:0001264 | 84.48 | gold quality |
| ileal mucosa | UBERON:0000331 | 84.43 | gold quality |
| female reproductive system | UBERON:0000474 | 84.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.26 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1976.1 | ZNF320 | More than 3 adjacent zinc fingers |
| MA1976.2 | ZNF320 | More than 3 adjacent zinc fingers |
| MA1976.3 | ZNF320 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
miRNA regulators (miRDB)
123 targeting ZNF320, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
Literature-anchored findings (GeneRIF, showing 1)
- ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle. (PMID:36287187)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 320 — A2RRD8 (reviewed: A2RRD8)
All UniProt accessions (7): A0A669KBJ2, A2RRD8, M0QX96, M0QZA2, M0R0Z8, M0R1K6, M0R2L4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Expressed at high levels in placenta, pancreas, kidney and heart, and at lower levels in liver, skeletal muscle and brain.
Disease relevance. A chromosomal aberration involving ZNF320 is found in a form of glioblastoma. Translocation t(10;19)(q26;q13.3) with BRWD2/WDR11.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (14): NP_001338702, NP_001338703, NP_001338704, NP_001338705, NP_001338706, NP_001374499, NP_001374500, NP_001374501, NP_001374502, NP_001374503, NP_001374504, NP_001374505, NP_001374506, NP_997216 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050589 | Ikaros_C2H2-ZF | Family |
Pfam: PF00096, PF01352
UniProt features (14 total): zinc finger region 12, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A2RRD8-F1 | 69.03 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 41 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, BASAKI_YBX1_TARGETS_DN, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, E2F2_TARGET_GENES, NFE2L1_TARGET_GENES, NFKBIA_TARGET_GENES, ZNF407_TARGET_GENES, MIR3646, MIR19A_3P, MIR19B_3P, MIR513A_3P_MIR513C_3P, MIR3133
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF320 | DMBT1 | Q9UGM3 | 825 |
| ZNF320 | PLAC8L1 | A1L4L8 | 432 |
| ZNF320 | LGALS16 | A8MUM7 | 426 |
| ZNF320 | MYEOV | Q96EZ4 | 382 |
| ZNF320 | CLC | Q05315 | 351 |
| ZNF320 | RNFT2 | Q96EX2 | 324 |
| ZNF320 | KRTAP3-3 | Q9BYR6 | 316 |
| ZNF320 | C9JR48 | C9JR48 | 305 |
| ZNF320 | TCEAL9 | Q9UHQ7 | 296 |
| ZNF320 | ERICH1 | Q86X53 | 291 |
| ZNF320 | TTC5 | Q8N0Z6 | 290 |
| ZNF320 | ENKUR | Q8TC29 | 280 |
| ZNF320 | MRPS25 | P82663 | 278 |
| ZNF320 | MRPS9 | P82933 | 276 |
| ZNF320 | RPL7L1 | Q6DKI1 | 272 |
IntAct
32 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF320 | KRTAP10-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF320 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-5 | ZNF320 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF320 | PPM1G | psi-mi:“MI:0914”(association) | 0.350 |
| RPL34 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL27A | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPS19 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL7L1 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| PURG | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF467 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FBLN5 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZKSCAN8 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| GOLGA8A | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NOP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF460 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| SPANXN2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF677 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| TIMM50 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPLP0 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RBM4B | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL4 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (29): KRTAP10-7 (Two-hybrid), KRTAP10-5 (Two-hybrid), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS), ZNF320 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 23 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Peptide chain elongation | 5 | 37.3× | 3e-06 |
| Viral mRNA Translation | 5 | 37.3× | 3e-06 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 5 | 36.9× | 3e-06 |
| Selenocysteine synthesis | 5 | 35.4× | 3e-06 |
| Eukaryotic Translation Termination | 5 | 35.4× | 3e-06 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 5 | 34.6× | 3e-06 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | 5 | 34.6× | 3e-06 |
| Formation of a pool of free 40S subunits | 5 | 32.9× | 3e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 5 | 46.3× | 8e-06 |
| translation | 5 | 25.7× | 7e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
74 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1237 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:52881981:TAT:T | acceptor_gain | 1.0000 |
| 19:52888119:AT:A | donor_gain | 1.0000 |
| 19:52888249:AGACC:A | acceptor_gain | 1.0000 |
| 19:52888250:GACC:G | acceptor_gain | 1.0000 |
| 19:52888252:CC:C | acceptor_gain | 1.0000 |
| 19:52888253:CC:C | acceptor_gain | 1.0000 |
| 19:52888253:CCT:C | acceptor_loss | 1.0000 |
| 19:52888254:C:CC | acceptor_gain | 1.0000 |
| 19:52888254:C:T | acceptor_gain | 1.0000 |
| 19:52888254:CTG:C | acceptor_loss | 1.0000 |
| 19:52888254:CTGAA:C | acceptor_loss | 1.0000 |
| 19:52888255:T:C | acceptor_loss | 1.0000 |
| 19:52890237:TCA:T | donor_loss | 1.0000 |
| 19:52890238:CA:C | donor_loss | 1.0000 |
| 19:52890240:C:CG | donor_loss | 1.0000 |
| 19:52890324:CAATC:C | acceptor_gain | 1.0000 |
| 19:52890327:TC:T | acceptor_gain | 1.0000 |
| 19:52890328:CC:C | acceptor_gain | 1.0000 |
| 19:52890329:CTAA:C | acceptor_loss | 1.0000 |
| 19:52890330:T:G | acceptor_loss | 1.0000 |
| 19:52881979:GATAT:G | acceptor_gain | 0.9900 |
| 19:52881984:C:CC | acceptor_gain | 0.9900 |
| 19:52881985:T:G | acceptor_loss | 0.9900 |
| 19:52888097:T:TA | donor_gain | 0.9900 |
| 19:52888098:C:A | donor_gain | 0.9900 |
| 19:52888121:CCTCA:C | donor_loss | 0.9900 |
| 19:52888122:CTCAC:C | donor_loss | 0.9900 |
| 19:52888123:TCA:T | donor_loss | 0.9900 |
| 19:52888124:C:CC | donor_loss | 0.9900 |
| 19:52888125:A:AC | donor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000047732 (19:52899683 G>A), RS1000188425 (19:52894365 CAG>C), RS1000220927 (19:52894618 A>T), RS1000280717 (19:52859069 A>G), RS1000523924 (19:52895805 G>T), RS1000554677 (19:52902887 A>C), RS1000555241 (19:52896098 T>C), RS1000568923 (19:52859582 G>A), RS1000606656 (19:52901421 G>A,T), RS1000646951 (19:52897272 C>A), RS1000648066 (19:52860017 A>G), RS1000772864 (19:52864314 A>G), RS1000832948 (19:52889709 A>G,T), RS1000861766 (19:52892668 A>G), RS1000904920 (19:52902491 C>G,T)
Disease associations
OMIM: gene MIM:606427 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001282_3 | Psychosis in Alzheimer’s disease | 5.000000e-06 |
| GCST90002393_671 | Monocyte count | 2.000000e-12 |
| GCST90002400_96 | Plateletcrit | 4.000000e-13 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005940 | psychotic symptoms |
| EFO:0005091 | monocyte count |
| EFO:0007985 | platelet crit |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 2 |
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| Endosulfan | decreases expression, increases expression | 2 |
| Aflatoxin B1 | increases methylation | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arbutin | decreases expression | 1 |
| Arsenic | increases expression, affects cotreatment, increases abundance | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Polychlorinated Biphenyls | affects expression | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.